Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Insmed Inc. (INSM)
Market Closed
17 Jul, 20:00
NASDAQ (NGS)
All
(8)
DE
(4)
IT
(1)
MX
(1)
GB
(1)
US
(1)
NASDAQ (NGS)
Primary
LSE
XFRA
XSTU
XMEX
XDUS
XMIL
XETRA
$
108.
32
+0.86
+0.8003%
$
25.06B
Market Cap
-
P/E Ratio
-
Div Yield
2M
Volume
-5.21
Eps
$
107.46
Previous Close
Investors:
TJD
LC
CE
ABB
JD
+126
Analysts:
Watching
Watch
Add Transaction
Day Range
105.2
110.58
Year Range
90.39
212.75
Want to track
INSM
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
News
Historical Data
Investors
Analysts
Insmed Inc. (INSM) Statistics
Valuation metrics
Market Cap
25.06B
Enterprise value
23.64B
Trailing P/E (ttm)
-18.84
Forward P/E
262.76
PEG ratio
-13.81
Price/Sales (ttm)
28.65
Price/Book (mrq)
33.11
Enterprise Value/Revenue
28.85
Enterprise Value/EBITDA
-21.87
Overview
Shares outstanding
216.52M
Float
198.27M
Shares short
14.71M
% Held by insiders
0.01%
% Held by institutions
1.05%
Average volume (10 days)
2.41M
Average volume (90 days)
3.28M
Price summary
52-Week low
90.39
52-Week high
212.75
Beta
0.89
50-Day moving average
106.33
200-Day moving average
142.05
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:10
Last split Date
3 Mar 2011
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-1.44%
Operating margin
-1.38%
Operational effectiveness
Return on assets
-0.57%
Return on equity
-1.3%
Income Statement
Revenue (ttm)
819.56M
Revenue per share (ttm)
3.8
Quarterly revenue growth (yoy)
2.3%
Gross profit (ttm)
670.48M
EBITDA
-949.04M
Net income to common (ttm)
-1.18B
Diluted EPS (ttm)
-5.49
Quarterly earnings growth (yoy)
2.3%
Balance Sheet
Total cash (mrq)
1.22B
Total cash per share (mrq)
5.68
Total debt (mrq)
742.46M
Total Debt/Equity (mrq)
1.06
Current ratio (mrq)
4.47%
Book value per share (mrq)
3.27
Cash Flow
Cash flow statement
-895.66M
Levered free cash flow (LFCF)
-606.2M